Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 81-1159359 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Our mission is to connect families, resources, and the medical community to advance research for a cure to Ddx3x gene mutations. Our ultimate goal over the coming years is to accelerate brain function in individuals affected by Ddx3x through advances in gene therapy and pharmaceuticals.
Principal Officer
Elizabeth Buccini
Total Revenue
$387K
FY2024
Total Expenses
$453K
FY2024
Net Assets
$60K
Program Ratio
67.3%
expenses on programs
Employees
2
Volunteers
—
Board Members
3
Voting
3
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.